Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05963633 · ClinicalTrials.gov registry record · NA

Future Thinking to Improve Parent-Child Relationships

A NA study of Behavior, Health, sponsored by Henry Ford Health System.

Active
Registry status
NA
Development phase
72
Enrollment target
1
Study location

NCT05963633: Active NA study of Behavior, Health, sponsored by Henry Ford Health System.

NCT05963633 is a NA study of Behavior, Health that is active but no longer recruiting, run by Henry Ford Health System. The registered enrollment target is 72 participants, below the 15,788-participant average among 20 other Behavior, Health trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05963633, a NA study of Behavior, Health, is active but no longer recruiting, sponsored by Henry Ford Health System.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
72 participants
Enrollment target
1
Study location

Study Summary

Parents with substance use disorders are disproportionately more likely to engage in harsh physical discipline, which can lead to serious clinical outcomes, including child maltreatment and the intergenerational transmission of addictive disorders. One mechanism linking substance use and maladaptive parenting strategies is parental delay discounting, or the tendency to value smaller, immediate rewards (such as stopping children's misbehavior via physical punishment) relative to larger, but delayed rewards (like shaping adaptive child behaviors over time). This study will examine the effectiveness of a brief, episodic future thinking (EFT) intervention in a substance use treatment setting to increase parents' focus on positive, future events associated with enhancing the parent-child relationship. This study will inform broader public health efforts aimed at reducing child maltreatment and interrupting intergenerational cycles of substance abuse in traditionally underserved communities.

Primary Outcome

The computer based adjusting amount discounting task uses an adjusting algorithm to determine the amount of immediately available money that is equivalent to a large sum that is delayed by seven discrete durations of time presented in a randomized order (i.e., 1 day, 1 week, 1 month, 6 months, 1 year, 5 years, and 25 years).At each delay, a choice is first presented between the delayed larger sum and a smaller sum available immediately. For each trial, the position of the delayed and immediate a

Conditions Studied

Interventions

  • BEHAVIORAL Episodic Future Thinking (EFT)
  • BEHAVIORAL Episodic Recent Thinking (ERT)

Study Locations (1)

Michigan

  • Odyssey Village - Flint

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2023-09-01
Est. Completion 2025-12-01
Phase NA
Henry Ford Health System

234 total trials

What the registry record for NCT05963633 still lists

NCT05963633 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 15,788-participant average among 20 other Behavior, Health trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Behavior, Health appearing as the primary indexed condition, and to 2 interventions - of which Episodic Future Thinking (EFT) is the first listed.

NCT05963633 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT05963633 about?

NCT05963633 is a clinical study titled "Future Thinking to Improve Parent-Child Relationships". Parents with substance use disorders are disproportionately more likely to engage in harsh physical discipline, which can lead to serious clinical outcomes, including child maltreatment and the intergenerational transmission of addictive disorders. One mechanism linking substance use and maladaptive...

What is the current status of trial NCT05963633?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 72 participants. The study started on 2023-09-01. Estimated completion is 2025-12-01.

What conditions does trial NCT05963633 study?

This clinical trial studies the following conditions: Behavior, Health.

What interventions are being tested in trial NCT05963633?

The interventions under investigation include: Episodic Future Thinking (EFT) (BEHAVIORAL), Episodic Recent Thinking (ERT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05963633?

This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05963633 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Behavior, Health

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05963633's enrollment target sits among peer trials

72 14th of 20 higher than 6 of 20 other Behavior, Health trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Behavior, Health trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02359253 · 72 participants · NA

    Robot Aided Rehabilitation - Intervention

  • NCT02962661 · 72 participants · Phase 1

    Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

  • NCT03113643 · 72 participants · Phase 1

    SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

  • NCT03187535 · 72 participants · NA

    Effect of TEAS on PONV After Spinal Surgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05963633, the US trial registry maintained by the National Library of Medicine. NCT05963633 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.